Anna Bibby joins The Lancet Oncology to discuss recent developments in the treament of malignant plural mesothelioma.

Anna Bibby joins The Lancet Oncology to discuss recent developments in the treament of malignant plural mesothelioma.

Anna Bibby joins&nbsp;The Lancet Oncology to discuss recent developments in the treament of&nbsp;malignant plural mesothelioma.

Malignant plural mesothelioma

The Lancet Oncology is a monthly journal, renowned for the publication of high-quality peer reviewed research, reviews and analysis in cancer from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue.

Share Malignant plural mesothelioma

Sign up to save your podcasts

Malignant plural mesothelioma

Malignant plural mesothelioma